Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

195 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
A PK-PD model linking biomarker dynamics to progression-free survival in patients treated with everolimus and sorafenib combination therapy, EVESOR phase I trial.
Puszkiel A, You B, Payen L, Lopez J, Guitton J, Rousset P, Fontaine J, Péron J, Maillet D, Tartas S, Bonnin N, Trillet-Lenoir V, Colomban O, Augu-Denechere D, Freyer G, Tod M. Puszkiel A, et al. Among authors: rousset p. Cancer Chemother Pharmacol. 2023 May;91(5):413-425. doi: 10.1007/s00280-023-04520-z. Epub 2023 Apr 3. Cancer Chemother Pharmacol. 2023. PMID: 37010549 Clinical Trial.
Successful pregnancy in a cancer patient previously cured of a gestational trophoblastic tumor by immunotherapy.
Bolze PA, You B, Lotz JP, Massardier J, Gladieff L, Joly F, Hajri T, Maucort-Boulch D, Bin S, Roux A, Rousset P, Villeneuve L, Alves-Ferreira M, Grazziotin-Soares D, Mercier C, Freyer G, Golfier F. Bolze PA, et al. Among authors: rousset p. Ann Oncol. 2020 Jun;31(6):823-825. doi: 10.1016/j.annonc.2020.02.015. Epub 2020 Mar 11. Ann Oncol. 2020. PMID: 32171750 Free article. No abstract available.
Avelumab in Patients With Gestational Trophoblastic Tumors With Resistance to Single-Agent Chemotherapy: Cohort A of the TROPHIMMUN Phase II Trial.
You B, Bolze PA, Lotz JP, Massardier J, Gladieff L, Joly F, Hajri T, Maucort-Boulch D, Bin S, Rousset P, Devouassoux-Shisheboran M, Roux A, Alves-Ferreira M, Grazziotin-Soares D, Langlois-Jacques C, Mercier C, Villeneuve L, Freyer G, Golfier F. You B, et al. Among authors: rousset p. J Clin Oncol. 2020 Sep 20;38(27):3129-3137. doi: 10.1200/JCO.20.00803. Epub 2020 Jul 27. J Clin Oncol. 2020. PMID: 32716740 Free PMC article. Clinical Trial.
Non-resectable Malignant Peritoneal Mesothelioma Treated with Pressurized Intraperitoneal Aerosol Chemotherapy (PIPAC) Plus Systemic Chemotherapy Could Lead to Secondary Complete Cytoreductive Surgery: A Cohort Study.
Kepenekian V, Péron J, You B, Bonnefoy I, Villeneuve L, Alyami M, Bakrin N, Rousset P, Benzerdjeb N, Glehen O. Kepenekian V, et al. Among authors: rousset p. Ann Surg Oncol. 2022 Mar;29(3):2104-2113. doi: 10.1245/s10434-021-10983-2. Epub 2021 Oct 28. Ann Surg Oncol. 2022. PMID: 34713369
Appendiceal tumors and pseudomyxoma peritonei: French Intergroup Clinical Practice Guidelines for diagnosis, treatments and follow-up (RENAPE, RENAPATH, SNFGE, FFCD, GERCOR, UNICANCER, SFCD, SFED, SFRO, ACHBT, SFR).
Delhorme JB, Villeneuve L, Bouché O, Averous G, Dohan A, Gornet JM, You B, Bibeau F, Dartigues P, Eveno C, Fontaine J, Kepenekian V, Pocard M, Rousset P, Quenet F, Mariani P, Glehen O, Goéré D. Delhorme JB, et al. Among authors: rousset p. Dig Liver Dis. 2022 Jan;54(1):30-39. doi: 10.1016/j.dld.2021.10.005. Epub 2021 Nov 20. Dig Liver Dis. 2022. PMID: 34815194
Advances in the management of peritoneal malignancies.
Kepenekian V, Bhatt A, Péron J, Alyami M, Benzerdjeb N, Bakrin N, Falandry C, Passot G, Rousset P, Glehen O. Kepenekian V, et al. Among authors: rousset p. Nat Rev Clin Oncol. 2022 Nov;19(11):698-718. doi: 10.1038/s41571-022-00675-5. Epub 2022 Sep 7. Nat Rev Clin Oncol. 2022. PMID: 36071285 Review.
Scalloping of the Liver and Spleen on Preoperative CT-Scan of Pseudomyxoma Peritonei Patients: Impact on Prediction of Resectability, Grade, Morbidity and Survival.
Kepenekian V, Kefleyesus A, Keskin D, Benzerdjeb N, Bonnefoy I, Villeneuve L, Alhadeedi O, Al-Otaibi A, Galan A, Glehen O, Péron J, Rousset P. Kepenekian V, et al. Among authors: rousset p. Cancers (Basel). 2022 Sep 13;14(18):4434. doi: 10.3390/cancers14184434. Cancers (Basel). 2022. PMID: 36139595 Free PMC article.
Avelumab in patients with gestational trophoblastic tumors with resistance to polychemotherapy: Cohort B of the TROPHIMMUN phase 2 trial.
You B, Bolze PA, Lotz JP, Massardier J, Gladieff L, Floquet A, Hajri T, Descargues P, Langlois-Jacques C, Bin S, Villeneuve L, Roux A, Alves-Ferreira M, Grazziotin-Soares D, Dherret G, Gerentet C, Rousset P, Freyer G, Golfier F. You B, et al. Among authors: rousset p. Gynecol Oncol. 2023 Jan;168:62-67. doi: 10.1016/j.ygyno.2022.11.005. Epub 2022 Nov 16. Gynecol Oncol. 2023. PMID: 36401942 Clinical Trial.
Comparison of Neoadjuvant Systemic Chemotherapy Protocols for the Curative-Intent Management of Peritoneal Metastases from Colorectal Cancer, Regarding Morphological Response, Pathological Response, and Long-Term Outcomes: A Retrospective Study.
Fanget F, Kefleyesus A, Peron J, Bonnefoy I, Villeneuve L, Passot G, Rousset P, You B, Benzerdjeb N, Glehen O, Kepenekian V. Fanget F, et al. Among authors: rousset p. Ann Surg Oncol. 2023 Jun;30(6):3304-3315. doi: 10.1245/s10434-023-13150-x. Epub 2023 Feb 2. Ann Surg Oncol. 2023. PMID: 36729351
195 results